Latest Regulatory Scrutiny News

Sequoia Financial Group reports robust FY25 growth with improved margins and a fully franked dividend, while navigating regulatory scrutiny and governance reforms.

Emu NL has lodged a formal review application against the Takeovers Panel's recent variation of orders, signaling continued regulatory tension in its takeover proceedings.

ASX has revealed it expects to incur an additional $25 million to $35 million in operating expenses in FY26 due to the ongoing ASIC compliance inquiry. Despite this, the company remains committed to its five-year strategy focused on technology and risk management.

Rhythm Biosciences has responded to an ASX price query following a sudden surge in its share price and trading volume, confirming no undisclosed information is driving the activity.

Hudson Investment Group faces intense scrutiny from ASX after its auditor issued a Disclaimer of Opinion on the 2024 financial report, citing doubts over a $2.4 million property receivable and the company’s going concern status.

Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.

The Lederer Group has announced an off-market takeover offer for all stapled securities in the Elanor Commercial Property Fund at 70 cents each, representing a premium over recent trading prices. The bid comes amid governance concerns and a proposed overhaul of the fund’s management structure.

Sequoia Financial Group has launched a dedicated AFSL Governance Committee to bolster oversight across its licenses, appointing former ASIC Commissioner Danielle Press as Independent Chair.

The Takeovers Panel has amended its orders for Emu NL, mandating a new shareholder meeting to consider expanded resolutions, including director removal proposals from Wayburn Holdings.

Alara Resources Limited has addressed an ASX query regarding the late filing of a director's interest notice, attributing the delay to complexities in share ownership disclosure. The company confirms existing compliance arrangements remain robust.

PointsBet Holdings has dismissed Betr Entertainment's increased scrip takeover offer, reaffirming its support for MIXI's competing bid amid ongoing regulatory scrutiny.

Cobre Limited’s CBEO securities have been suspended from trading pending regulatory compliance, raising questions about the company’s next steps and investor impact.